186 related articles for article (PubMed ID: 22932866)
1. Induction of chlamydospore formation in fusarium by cyclic lipopeptide antibiotics from Bacillus subtilis C2.
Li L; Ma M; Huang R; Qu Q; Li G; Zhou J; Zhang K; Lu K; Niu X; Luo J
J Chem Ecol; 2012 Aug; 38(8):966-74. PubMed ID: 22932866
[TBL] [Abstract][Full Text] [Related]
2. Lipopeptides from an isolate of Bacillus subtilis complex have inhibitory and antibiofilm effects on Fusarium solani.
Santos-Lima D; de Castro Spadari C; de Morais Barroso V; Carvalho JCS; de Almeida LC; Alcalde FSC; Ferreira MJP; Sannomiya M; Ishida K
Appl Microbiol Biotechnol; 2023 Oct; 107(19):6103-6120. PubMed ID: 37561179
[TBL] [Abstract][Full Text] [Related]
3. Fungal Competitors Affect Production of Antimicrobial Lipopeptides in Bacillus subtilis Strain B9-5.
DeFilippi S; Groulx E; Megalla M; Mohamed R; Avis TJ
J Chem Ecol; 2018 Apr; 44(4):374-383. PubMed ID: 29492723
[TBL] [Abstract][Full Text] [Related]
4. ESI LC-MS and MS/MS characterization of antifungal cyclic lipopeptides produced by Bacillus subtilis XF-1.
Li XY; Mao ZC; Wang YH; Wu YX; He YQ; Long CL
J Mol Microbiol Biotechnol; 2012; 22(2):83-93. PubMed ID: 22614917
[TBL] [Abstract][Full Text] [Related]
5. Cyclic lipopeptide profile of three Bacillus subtilis strains; antagonists of Fusarium head blight.
Dunlap CA; Schisler DA; Price NP; Vaughn SF
J Microbiol; 2011 Aug; 49(4):603-9. PubMed ID: 21887643
[TBL] [Abstract][Full Text] [Related]
6. Fengycins, Cyclic Lipopeptides from Marine Bacillus subtilis Strains, Kill the Plant-Pathogenic Fungus Magnaporthe grisea by Inducing Reactive Oxygen Species Production and Chromatin Condensation.
Zhang L; Sun C
Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 29980550
[TBL] [Abstract][Full Text] [Related]
7. Improved Production of Two Anti-
Ramchandran R; Ramesh S; A A; Thakur R; Chakrabarti A; Roy U
Curr Pharm Biotechnol; 2020; 21(5):438-450. PubMed ID: 31804165
[TBL] [Abstract][Full Text] [Related]
8. A Novel Variant of Narrow-Spectrum Antifungal Bacterial Lipopeptides That Strongly Inhibit Ganoderma boninense.
Pramudito TE; Agustina D; Nguyen TKN; Suwanto A
Probiotics Antimicrob Proteins; 2018 Mar; 10(1):110-117. PubMed ID: 29101528
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Fusarium graminearum inhibitory lipopeptide from Bacillus subtilis IB.
Wang J; Liu J; Chen H; Yao J
Appl Microbiol Biotechnol; 2007 Sep; 76(4):889-94. PubMed ID: 17611753
[TBL] [Abstract][Full Text] [Related]
10. Screening of a Bacillus subtilis Strain Producing Multiple Types of Cyclic Lipopeptides and Evaluation of Their Surface-tension-lowering Activities.
Habe H; Taira T; Imura T
J Oleo Sci; 2017; 66(7):785-790. PubMed ID: 28674328
[TBL] [Abstract][Full Text] [Related]
11. Antifungal efficiency of a lipopeptide biosurfactant derived from Bacillus subtilis SPB1 versus the phytopathogenic fungus, Fusarium solani.
Mnif I; Hammami I; Triki MA; Azabou MC; Ellouze-Chaabouni S; Ghribi D
Environ Sci Pollut Res Int; 2015 Nov; 22(22):18137-47. PubMed ID: 26178831
[TBL] [Abstract][Full Text] [Related]
12. Purification and identification of Bacillus subtilis SPB1 lipopeptide biosurfactant exhibiting antifungal activity against Rhizoctonia bataticola and Rhizoctonia solani.
Mnif I; Grau-Campistany A; Coronel-León J; Hammami I; Triki MA; Manresa A; Ghribi D
Environ Sci Pollut Res Int; 2016 Apr; 23(7):6690-9. PubMed ID: 26645234
[TBL] [Abstract][Full Text] [Related]
13. Qualitative analysis of biosurfactants from Bacillus species exhibiting antifungal activity.
Sarwar A; Brader G; Corretto E; Aleti G; Ullah MA; Sessitsch A; Hafeez FY
PLoS One; 2018; 13(6):e0198107. PubMed ID: 29864153
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory activity of bacterial lipopeptides against Fusarium oxysporum f.sp. Strigae.
Assena MW; Pfannstiel J; Rasche F
BMC Microbiol; 2024 Jun; 24(1):227. PubMed ID: 38937715
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of lipopeptide antibiotics produced by Bacillus subtilis.
Chen H; Wang L; Su CX; Gong GH; Wang P; Yu ZL
Lett Appl Microbiol; 2008 Sep; 47(3):180-6. PubMed ID: 19552782
[TBL] [Abstract][Full Text] [Related]
16. Bacillopeptins, new cyclic lipopeptide antibiotics from Bacillus subtilis FR-2.
Kajimura Y; Sugiyama M; Kaneda M
J Antibiot (Tokyo); 1995 Oct; 48(10):1095-103. PubMed ID: 7490214
[TBL] [Abstract][Full Text] [Related]
17. Production of biosurfactant lipopeptides Iturin A, fengycin and surfactin A from Bacillus subtilis CMB32 for control of Colletotrichum gloeosporioides.
Kim PI; Ryu J; Kim YH; Chi YT
J Microbiol Biotechnol; 2010 Jan; 20(1):138-45. PubMed ID: 20134245
[TBL] [Abstract][Full Text] [Related]
18. New Paenibacillus strain produces a family of linear and cyclic antimicrobial lipopeptides: cyclization is not essential for their antimicrobial activity.
Huang E; Yang X; Zhang L; Moon SH; Yousef AE
FEMS Microbiol Lett; 2017 Apr; 364(8):. PubMed ID: 28333237
[TBL] [Abstract][Full Text] [Related]
19. Isolation and yield optimization of lipopeptides from Bacillus subtilis Z-14 active against wheat take-all caused by Gaeumannomyces graminis var. tritici.
Zhang X; Chen X; Qiao X; Fan X; Huo X; Zhang D
J Sep Sci; 2021 Feb; 44(4):931-940. PubMed ID: 33326164
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel surfactin derivatives from NRPS modification of Bacillus subtilis and its antifungal activity against Fusarium moniliforme.
Jiang J; Gao L; Bie X; Lu Z; Liu H; Zhang C; Lu F; Zhao H
BMC Microbiol; 2016 Mar; 16():31. PubMed ID: 26957318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
